GEN Exclusives

More »

GEN News Highlights

More »
Jun 5, 2007

Valeant Pharmaceuticals Sells Manufacturing Facilities in Switzerland and Puerto Rico

  • Valeant Pharmaceuticals signed an agreement to sell its manufacturing facilities in Humacao, Puerto Rico, and Basel, Switzerland, to Legacy Pharmaceuticals. Terms of the transaction were not disclosed. Additionally, the sale includes the divestiture of the company’s product Reptilase.

    “The sale of the two manufacturing sites in Basel and Humacao represents the final step in our restructuring initiative, most of which was completed last year,” reported Timothy C. Tyson, Valeant's president and CEO.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?